Hyundai ADM Bio said Monday that it is working on a new drug, Penetrium, which is intended to help enhance the efficiency of ...

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Bayer said its Nubeqa treatment was approved by the EU for advanced prostate cancer. The German pharmaceutical and agricultural conglomerate said the European Commission granted approval of Nubeqa in ...

The Pension Fund Operators Association of Nigeria has held a knowledge-sharing session to sensitise young professionals within the industry to cancer and boost overall well-being within the ...

A phase 2 trial shows promising safety results for carotuximab in treating advanced prostate cancer, offering hope for ...

An expert discusses how radiopharmaceuticals such as radium-223 offer a valuable different mechanism of action in treating advanced prostate cancer, requiring careful patient selection, safety ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Cubs legend and Baseball Hall of Fame member Ryne Sandberg provided an update on health Wednesday morning in a statement ...